On November 17, 2021, federal agencies released an interim final rule requiring health plans and issuers to report information regarding the cost of prescription drugs and certain medical expenses. This rule is a continuation of the Biden administration’s efforts to promote greater transparency in health care spending.
For 2020 and 2021 information, reporting must be submitted by December 27, 2022, and by June 1 of year thereafter. Starting in 2023, federal agencies will issue biennial public reports on prescription drug pricing trends as well as the impact of prescription drug costs on premiums and out-of-pocket costs.
Many employee benefits are subject to annual dollar limits that are periodically updated for inflation.
The IRS typically announces the dollar limits that will apply for the next calendar year well before the beginning of that year. This gives employers time to update their plan designs and ensure that their plan administration will be consistent with the new limits. Although most of the limits will increase for 2022, some of the limits remain the same.
For plan years beginning on or after January 1, 2022, the following limits have increased:
Certain limits will not change for 2022, including the HDHP minimum deductible and catch-up contribution limits to HSAs or 401(k) plans. The tax exclusion for dependent care FSA benefits also returns to traditional rules.
The information contained within these materials are confidential and not to be distributed. Use of and access to this information, site, or any of the links contained within this document does not create a relationship between the recipient and CoverEase.